Delphinus Medical Technologies

Delphinus Medical Technologies, LLC develops, commercializes, sells, and services the breast cancer screening solutions to hospitals and imaging clinics in the United States and internationally. It commercializes SoftVue, a three-dimensional and tomographic ultrasound imaging and risk assessment device that examines women's breasts for the presence of benign and/or malignant masses, assesses breast cancer risks, diagnoses breast diseases, and monitors therapy. The company was founded in 2009 and is based in Detroit, Michigan.

Type
Private
HQ
Novi, US
Founded
2010
Employees
49 (est)-2%
Delphinus Medical Technologies was founded in 2010 and is headquartered in Novi, US

Delphinus Medical Technologies Locations

Novi, US
Sunnyvale, US

Delphinus Medical Technologies Metrics

Delphinus Medical Technologies Summary

Founding Date

2010

Total Funding

$58.5 M

Latest funding size

$39.5 M

Time since last funding

over 1 year

Investors

We estimate that Delphinus Medical Technologies's latest funding round in September 2015 was $39.5 M. In total, Delphinus Medical Technologies has raised $58.5 M

Delphinus Medical Technologies Company Life